Neuroprotective Effects of Neuropeptide Y and Y2 and Y5 Receptor Agonists In Vitro and In Vivo

QR Code

Neuroprotective Effects of Neuropeptide Y and Y2 and Y5 Receptor Agonists In Vitro and In Vivo

None

Saved in:

Bibliographic Details
Main Authors:	Smialowska, Maria, Domin, Helena
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/35191
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Neuropeptide Kyotorphin as a Possible Biomarker and Neuroprotective Agent in Alzheimer’s Disease
by: Hristina Angelova, et al.
Published: (2020-09-01)

Expression of Neuropeptide Y of GIFT Tilapia (Oreochromis sp.) in Yeast Pichia Pastoris and Its Stimulatory Effects on Food Intake and Growth
by: Wang, Guangzhong, et al.
Published: (2011)

Vasoactive Neuropeptides in Autoimmune Diseases
by: Brenu, Ekua W., et al.
Published: (2011)

Role of neuropeptide Y in development of valproate-induced eating behaviour disorder
by: N. A. Shnayder, et al.
Published: (2025-01-01)

Distribution of neuropeptide Y immunoreactive nerve fibers and cells in Alligator's heart
by: ZHANG Jia-xing, et al.
Published: (2001-11-01)

Transcriptome-Wide Identification of Neuropeptides and Neuropeptide Receptors in the Twenty-Eight-Spotted Ladybird <i>Henosepilachna vigintioctopunctata</i>
by: Quanxing Lei, et al.
Published: (2025-06-01)

Research of neuroprotective properties of TrkA-receptor agonist GK-2 on model of oxidative stress in human vascular endothelial cells (HUVEC)
by: T. A. Antipova, et al.
Published: (2019-01-01)

Opioid Kappa Receptor Selective Agonist TRK-820 (Nalfurafine Hydrochloride)
by: Fujii, Hideaki, et al.
Published: (2012)

Drug Design Approaches to Manipulate the Agonist-Antagonist Equilibrium in Steroid Receptors
by: Lusher, Scott J., et al.
Published: (2012)

Inhibition of Advanced Prostate Cancer by Androgens and Liver X Receptor Agonists
by: Chuu, Chih-Pin, et al.
Published: (2011)

Screening the function of genes encoding neuropeptides and their receptors in Nilaparvata lugens
by: WANG Siliang, et al.
Published: (2022-12-01)

The Protective Effects of Pre-Treatment with Glutamate Metabotropic Receptor Agonists on the Development of Parkinsonian Movements
by: Qazzaz, Munir, et al.
Published: (2011)

Fructose-induced synaptic and neuronal adaptations at neuropeptide Y/agouti-related peptide neurons
by: Mikayla A. Payant, et al.
Published: (2025-09-01)

The Role of the Neuropeptide Substance P in the Pathogenesis of Parkinson’s Disease
by: Thornton, Emma, et al.
Published: (2012)

The Effects of Topiramate and Flunarizine on serum Glutamine and neuropeptide Y levels in adolescent Rats with a Migraine model
by: Nesrin Ceylan, et al.
Published: (2025-07-01)

Beyond boundaries: Neuroprotective effects of steroids and ecdysteroids in SH‐SY5Y cells ‐ A systematic review
by: Bizhar Ahmed Tayeb, et al.
Published: (2024-06-01)

Neuropeptide Y mRNA expression in the aging inferior colliculus of fischer brown norway rats
by: Laila S. Almassri, et al.
Published: (2025-07-01)

In Vitro and In Vivo Anti-Helicobacter pylori Activity of Natural Products
by: Souza, Maria do Carmo
Published: (2011)

Neuroprotection in Glaucoma
by: II, Brett H. Mueller, et al.
Published: (2011)

Modeling Huntington’s Disease: in vivo, in vitro, in silico
by: Tunalı, Nagehan Ersoy
Published: (2012)

Reduced Antinociceptive Effect of Repeated Treatment with a Cannabinoid Receptor Type 2 Agonist in Cannabinoid-Tolerant Rats Following Spinal Nerve Transection
by: Alkaitis, Matthew S., et al.
Published: (2012)

Neuroprotection and Pain Management
by: Hassanzadeh, Kambiz, et al.
Published: (2012)

Neuroprotective Agents in Glaucoma
by: Bagli, Eleni, et al.
Published: (2011)

Significance of FXa and its receptor PAR2 for the growth of colon cancer cells in vitro and in vivo
by: Ulrike Meyer, et al.
Published: (2025-07-01)

β2-Adrenoceptor Agonists and Allergic Disease: The Enhancing Effect of β2-Adrenoceptor Agonists on Cytokine-Induced TSLP Production by Human Lung Tissue Cells
by: Matsuda, Akio, et al.
Published: (2012)

The role of neuropeptides (oxytocin, vasopressin, neuropeptide S) in the development of cognitive impairment in Alzheimer’s disease
by: A. M. Avliyakulyeva, et al.
Published: (2024-04-01)

In Vitro and In Vivo Transactivation of HIV-1 by Human Herpesvirus 6
by: Joseph, Ongrádi, et al.
Published: (2011)

Biomaterials Applicable for Alveolar Sockets Preservation: In Vivo and In Vitro Studies
by: Kunert-Keil, Christiane, et al.
Published: (2011)

Neuroprotective role of acamprosate and rasagiline in epilepsy: In silico and in vivo study
by: Kumar Sandeep, et al.
Published: (2025-01-01)

Place of imidazoline receptor agonists in the treatment of hypertension
by: D. V. Nebieridze, et al.
Published: (2022-01-01)

Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01)

Peroxisome Proliferator Activated Receptor Alpha (PPAR) Agonists: A Potential Tool for a Healthy Aging Brain
by: Tremblay-Mercier, Jennifer
Published: (2012)

Neuroprotective properties of novel substituted glyprolines in vitro
by: T. A. Antipova, et al.
Published: (2019-10-01)

Molecular Imaging of 7 Nicotinic Acetylcholine Receptors In Vivo: Current Status and Perspectives
by: Brust, Peter, et al.
Published: (2012)

PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET
by: L. V. Egshatyan, et al.
Published: (2015-09-01)

Impaired Sociability of the Balb/c Mouse, an Animal Model of Autism Spectrum Disorders, is Attenuated by NMDA Receptor Agonist Interventions: Clinical Implications
by: Deutsch, Stephen I., et al.
Published: (2011)

Incretin-Based Treatment Strategy - GLP-1 Receptor Agonists (GLP-1R) or So-Called Incretin Mimetics
by: Perusicova, Jindra, et al.
Published: (2011)

Melanocortins: Anti-Inflammatory and Neuroprotective Peptides
by: Caruso, Carla, et al.
Published: (2012)

Free Radicals, Neuronal Death and Neuroprotection
by: Gallego, Diana, et al.
Published: (2011)

Place of imidazoline receptor agonists in the treatment of arterial hypertension
by: D. V. Nebieridze, et al.
Published: (2023-12-01)